Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ukraine Medical Donations Flood In As Government Continues To Ease Product Use Rules

Value of remote technologies being proven during conflict

Executive Summary

Medical support is arriving in Ukraine in more significant volumes, and rules facilitating medical product use continue to be put in place by the government against the backdrop of the Russian invasion and worsening humanitarian tragedy.

You may also be interested in...



Recalls And Multiple Market Challenges Test Philips’ Resilience Into Q1

Philips’ revenues contraction in the first quarter of 2022 was less than feared and its order book remains impressive, but challenges presented by the recall program and generic post-COVID factors for the year ahead remain substantial.

Ukraine Wants Medtech Business As Usual Even As Russian Siege Intensifies

The medtech supply chain is damaged and humanitarian aid needs are rising after two weeks of the Russian military invasion of Ukraine. The government is addressing the emergency situation while driving to maintain business as usual for the sake of the economy.

Ukraine Under Martial Law Calls For Medical Supplies As Medtechs Adjust And Respond

Martial law in Ukraine following the military onslaught and invasion by Russian forces has compelled the health ministry and industry to put emergency plans in place.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT145205

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel